# Phase 07 Execution Evidence

## F07-T01 — lifecycle draft/issue/amend و قواعد ایمنی نسخه

Task ID: F07-T01
Completed at: 2026-09-03 22:08 +03:30
Agent/Thread: Codex /root
Batch ID: F07-B01
Reviewed by: Codex /root
Changed files:

- `plan/contracts/prescription-treatment-policy-v1.md`
- `plan/STATUS.md`
- `plan/phases/07-PRESCRIPTION-TREATMENT.md`
- `plan/logs/phase-07.md`
- `specs/005-adopt-phase-07/{spec.md,plan.md,research.md,data-model.md,quickstart.md,checklists/requirements.md,contracts/phase-07-adoption.md,tasks.md}`

Migrations: none.

Tests run:

- Policy traceability script against the owner-approved F07-T01 issuer, acknowledgement, immutability, audit/privacy, and legal-boundary requirements → PASS
- `git diff --check` → PASS
- Coordinator review of roadmap, engineering standards, approved F07-T01 policy, and Phase 06 clinical-policy boundary → PASS

Result:

- Existing single-dashboard scope is preserved; no role-management UI, additional dashboard, or Phase 08 work is introduced → PASS
- Drafts are editable, issued revisions are immutable, and corrections are append-only successor revisions with preserved issuance evidence → PASS
- Issuance requires `PRESCRIPTION_ISSUE` plus tenant/resource authorization; `DOCTOR` is the default issuer and `ADMIN`/`STAFF` receive no implicit authority → PASS
- Advisory warnings require exact-revision acknowledgement; only an approved `NON_OVERRIDABLE` rule blocks issuance, and no such rule is invented → PASS
- Safety acknowledgement, audit/privacy, AI prohibition, and unresolved jurisdiction-specific legal boundary are frozen without claiming compliance → PASS

Known limitations:

- This policy task adds no prescription persistence, API, UI, generated client, RBAC-management infrastructure, warning evaluator, or audit implementation. Those remain owned by `F07-T02`–`F07-T11`.

Next batch:

- `F07-B02` — `F07-T02` (unclaimed).
